Search Results for: DCP2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ACKR2 atypical chemokine receptor 2
  • Chemokine receptors bind chemokines
Novel CYP27A1 cytochrome P450 family 27 subfamily A member 1
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Synthesis of bile acids and bile salts via 24-hydroxycholesterol
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Endogenous sterols
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Cerebrotendinous xanthomatosis; Van Bogaert-Scherer-Epstein Disease
Novel EPB41L4A erythrocyte membrane protein band 4.1 like 4A
Novel FEM1C fem-1 homolog C
  • Neddylation
Novel KCNN2 potassium calcium-activated channel subfamily N member 2
  • Ca2+ activated K+ channels
  • Procaine
  • Miconazole
  • Trimebutine
Novel MAPK3 mitogen-activated protein kinase 3
  • MAPK3 (ERK1) activation
  • RAF-independent MAPK1/3 activation
  • ISG15 antiviral mechanism
  • Spry regulation of FGF signaling
  • Frs2-mediated activation
  • ERK/MAPK targets
  • ERK/MAPK targets
  • ERKs are inactivated
  • Regulation of actin dynamics for phagocytic cup formation
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Oncogene Induced Senescence
  • FCERI mediated MAPK activation
  • Regulation of HSF1-mediated heat shock response
  • NCAM signaling for neurite out-growth
  • RSK activation
  • Signal transduction by L1
  • Activation of the AP-1 family of transcription factors
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Negative regulation of FGFR1 signaling
  • Negative regulation of FGFR2 signaling
  • Negative regulation of FGFR3 signaling
  • Negative regulation of FGFR4 signaling
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate NADPH Oxidases
  • RAF/MAP kinase cascade
  • MAP2K and MAPK activation
  • Negative feedback regulation of MAPK pathway
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • RNA Polymerase I Promoter Opening
  • Signal attenuation
  • Advanced glycosylation endproduct receptor signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • ESR-mediated signaling
  • RUNX2 regulates osteoblast differentiation
  • Regulation of PTEN gene transcription
  • Regulation of the apoptosome activity
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Suppression of apoptosis
  • Signaling downstream of RAS mutants
  • Signaling by MAP2K mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated phagocytosis
  • Growth hormone receptor signaling
  • Sulindac
  • Acetylsalicylic acid
  • Minocycline
  • Arsenic trioxide
  • Purvalanol
  • 5-iodotubercidin
  • Seliciclib
  • Cholecystokinin
  • Ulixertinib
Novel MX1 MX dynamin like GTPase 1
  • ISG15 antiviral mechanism
  • Interferon alpha/beta signaling
Novel TMED7 transmembrane p24 trafficking protein 7
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
AGO1 argonaute RISC component 1
  • Pre-NOTCH Transcription and Translation
  • MicroRNA (miRNA) biogenesis
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • Ca2+ pathway
  • Small interfering RNA (siRNA) biogenesis
  • Post-transcriptional silencing by small RNAs
  • Transcriptional regulation by small RNAs
  • TP53 Regulates Metabolic Genes
  • MAPK6/MAPK4 signaling
  • Transcriptional Regulation by VENTX
  • Regulation of RUNX1 Expression and Activity
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • Regulation of PTEN mRNA translation
  • Competing endogenous RNAs (ceRNAs) regulate PTEN translation
  • Transcriptional Regulation by MECP2
  • Transcriptional Regulation by MECP2
  • Estrogen-dependent gene expression
  • Regulation of MECP2 expression and activity
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
AGO2 argonaute RISC catalytic component 2
  • Pre-NOTCH Transcription and Translation
  • MicroRNA (miRNA) biogenesis
  • Ca2+ pathway
  • Small interfering RNA (siRNA) biogenesis
  • Post-transcriptional silencing by small RNAs
  • Transcriptional regulation by small RNAs
  • TP53 Regulates Metabolic Genes
  • MAPK6/MAPK4 signaling
  • Regulation of RUNX1 Expression and Activity
  • Regulation of PTEN mRNA translation
  • Competing endogenous RNAs (ceRNAs) regulate PTEN translation
  • Transcriptional Regulation by MECP2
  • Transcriptional Regulation by MECP2
  • Estrogen-dependent gene expression
  • Regulation of MECP2 expression and activity
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
DCP1A decapping mRNA 1A
  • mRNA decay by 5' to 3' exoribonuclease
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
DCP1B decapping mRNA 1B
  • mRNA decay by 5' to 3' exoribonuclease
MIR15B microRNA 15b
MTOR mechanistic target of rapamycin kinase
  • PIP3 activates AKT signaling
  • Macroautophagy
  • MTOR signalling
  • mTORC1-mediated signalling
  • HSF1-dependent transactivation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • CD28 dependent PI3K/Akt signaling
  • VEGFR2 mediated vascular permeability
  • TP53 Regulates Metabolic Genes
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • Regulation of PTEN gene transcription
  • Amino acids regulate mTORC1
  • Pimecrolimus
  • Sirolimus
  • Everolimus
  • Rimiducid
  • SF1126
  • XL765
  • Ridaforolimus
  • Temsirolimus
  • Fostamatinib
NAGK N-acetylglucosamine kinase
  • Synthesis of UDP-N-acetyl-glucosamine
  • N-Acetylglucosamine
POLA2 DNA polymerase alpha 2, accessory subunit
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Polymerase switching on the C-strand of the telomere
  • Telomere C-strand synthesis initiation
  • DNA replication initiation
  • Activation of the pre-replicative complex
  • Polymerase switching
  • Removal of the Flap Intermediate
  • Processive synthesis on the lagging strand
  • Dacarbazine
PSMB1 proteasome 20S subunit beta 1
  • Activation of NF-kappaB in B cells
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • ER-Phagosome pathway
  • Cross-presentation of soluble exogenous antigens (endosomes)
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • SCF-beta-TrCP mediated degradation of Emi1
  • APC/C:Cdc20 mediated degradation of Securin
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Cdc20:Phospho-APC/C mediated degradation of Cyclin A
  • Vpu mediated degradation of CD4
  • Vif-mediated degradation of APOBEC3G
  • SCF(Skp2)-mediated degradation of p27/p21
  • Degradation of beta-catenin by the destruction complex
  • Downstream TCR signaling
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Separation of Sister Chromatids
  • FCERI mediated NF-kB activation
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Regulation of ornithine decarboxylase (ODC)
  • ABC-family proteins mediated transport
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • Asymmetric localization of PCP proteins
  • Degradation of AXIN
  • Degradation of DVL
  • Hedgehog ligand biogenesis
  • Hh mutants are degraded by ERAD
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • Degradation of GLI1 by the proteasome
  • Degradation of GLI2 by the proteasome
  • GLI3 is processed to GLI3R by the proteasome
  • Hedgehog 'on' state
  • Regulation of RAS by GAPs
  • TNFR2 non-canonical NF-kB pathway
  • NIK-->noncanonical NF-kB signaling
  • Defective CFTR causes cystic fibrosis
  • MAPK6/MAPK4 signaling
  • UCH proteinases
  • Ub-specific processing proteases
  • Neutrophil degranulation
  • CDT1 association with the CDC6:ORC:origin complex
  • Orc1 removal from chromatin
  • CDK-mediated phosphorylation and removal of Cdc6
  • G2/M Checkpoints
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • Ubiquitin-dependent degradation of Cyclin D
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Regulation of RUNX2 expression and activity
  • Regulation of RUNX2 expression and activity
  • Regulation of RUNX3 expression and activity
  • Regulation of PTEN stability and activity
  • Neddylation
  • Regulation of expression of SLITs and ROBOs
  • Interleukin-1 signaling
  • Negative regulation of NOTCH4 signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Bortezomib
  • (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE
  • Carfilzomib
TRIM21 tripartite motif containing 21
  • STING mediated induction of host immune responses
  • Regulation of innate immune responses to cytosolic DNA
  • Interferon gamma signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
UPF1 UPF1 RNA helicase and ATPase
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
UPF2 UPF2 regulator of nonsense mediated mRNA decay
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)

Page 1 out of 1 pages